| Ident. | Authors (with country if any) | Title |
|---|
| 000104 |
WEI SONG [Canada] ; Hillel Zukor [Canada] ; Shih-Hsiung Lin [Canada] ; Adrienne Liberman [Canada] ; Ayda Tavitian [Canada] ; Jeannie Mui [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment |
| 000120 |
Sébastien Helie [États-Unis] ; Erick J. Paul [États-Unis] ; F. Gregory Ashby [États-Unis] | Simulating the effects of dopamine imbalance on cognition: From positive affect to Parkinson's disease |
| 000196 |
Ibrahim Mustafa [Canada] ; Ali Elkamel [Canada] ; Ali Lohi [Canada] ; PU CHEN [Canada] ; Said S. E. H. Elnashaie [Malaisie] ; Gamal Ibrahim [Égypte] | Application of continuation method and bifurcation for the acetylcholine neurocycle considering partial dissociation of acetic acid |
| 000225 |
Amit Bar-Or [Canada] ; Peter Rieckmann [Canada] ; Anthony Traboulsee [Canada] ; V. Wee Yong [Canada] | Targeting Progressive Neuroaxonal Injury: Lessons from Multiple Sclerosis |
| 000270 |
Edward A. Neuwelt [États-Unis] ; Björn Bauer [États-Unis] ; Christoph Fahlke [Allemagne] ; Gert Fricker [Allemagne] ; Constantino Iadecola [États-Unis] ; Damir Janigro [États-Unis] ; Luc Leybaert [Belgique] ; Zoltán Molnar [Royaume-Uni] ; Martha E. O'Donnell [États-Unis] ; John T. Povlishock [États-Unis] ; Norman R. Saunders [Australie] ; Frank Sharp [États-Unis] ; Danica Stanimirovic [Canada] ; Ryan J. Watts [États-Unis] ; Lester R. Drewes [États-Unis] | Engaging neuroscience to advance translational research in brain barrier biology |
| 000464 |
Hyman M. Schipper [Canada] ; WEI SONG [Canada] ; Hillel Zukor [Canada] ; Jacob R. Hascalovici [Canada] ; David Zeligman [Canada] | Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement |
| 000624 |
XINGSHUN XU [États-Unis] ; Chu C. Chua [États-Unis] ; JIMING KONG [Canada] ; Richard M. Kostrzewa [États-Unis] ; Udayasankar Kumaraguru [États-Unis] ; Ronald C. Hamdy [États-Unis] ; Balvin H. L. Chua [États-Unis] | Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells |
| 000685 |
Fannie St-Gelais [Canada] ; Claudia Jomphe [Canada] ; Louis-Eric Trudeau [Canada] | The role of neurotensin in central nervous system pathophysiology : What is the evidence? |
| 000812 |
Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | Chymotrypsin-like proteases contribute to human monocytic THP-1 cell as well as human microglial neurotoxicity |
| 000824 |
GUOWEI HUANG [Canada, République populaire de Chine] ; Magdalena Dragan [Canada] ; David Freeman [Canada] ; John X. Wilson [Canada, États-Unis] | Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons |
| 000966 |
Pierre J. Blanchet [États-Unis, Canada] ; Spiros Konitsiotis [États-Unis, Grèce] ; Hideki Mochizuki [États-Unis, Japon] ; Ryszard Pluta [États-Unis] ; Dwaine F. Emerich [États-Unis] ; Thomas N. Chase [États-Unis] ; M. Maral Mouradian [États-Unis] | Complications of a trophic xenotransplant approach in parkinsonian monkeys |
| 000993 |
Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie] | Role of serotonin2C receptors in the control of brain dopaminergic function |
| 000A13 |
Frédéric Calon [Canada] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias |
| 000A37 |
Nicole Duchesne [Canada] ; Jean-Paul Soucy [Canada] ; Hélène Masson [Canada] ; Sylvain Chouinard [Canada] ; Marc-André Bedard [Canada] | Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: A single photon emission computed tomography study using 123Iodine-β-CIT in patients on and OFF levodopa |
| 000A43 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Othman Ghribi [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Alteration of glutamate receptors in the striatum of dyskinetic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment |
| 000B14 |
Jun-Xia Xie [République populaire de Chine] ; MING TANG [République populaire de Chine] ; CHUNYI ZHANG [Canada] | Effect of cholecystokinin-8 microinjection into ventral tegmental area on dopamine release in nucleus accumbens of rats: An in vivo voltammetric study |
| 000B60 |
M. Goulet [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; S. Maltais [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-Monkeys |
| 000C55 |
M. S. Kallos [Canada] ; L. A. Behie [Canada] ; A. L. Vescovi [Italie] | Extended serial passaging of mammalian Neural stem cells in suspension bioreactors |
| 000C62 |
R. Grondin [Canada] ; M. Goulet [Canada] ; M. Morissette [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958 |
| 000D33 |
T. M. Peters [Canada] ; R. M. Comeau [Canada] ; R. Kasrai [Canada] ; P. S. Jean [Canada] ; D. Clonda [Canada] ; M. Sinasac [Canada] ; M. Audette [Canada] ; A. Fenster [Canada] | A comprehensive approach to image-guided surgery |
| 000D46 |
J. P. Francke [France] ; R. Sigal [France] ; P. Martinat [France] ; J. P. Pruvo [France] | Anatomie sérielle et IRM des noyaux de la base et du thalamus |
| 000E17 |
L. Wahl [Canada] ; C. Nahmias [Canada] | Modeling of fluorine-18-6-fluoro-L-Dopa in humans |
| 000E23 |
D. Boismenu [Canada] ; O. Mamer [Canada] ; L. Ste-Marie [Canada] ; L. Vachon [Canada] ; J. Montgomery [Canada] | In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors : Electrospray-MS analysis of intra-striatal microdialysates |
| 000F51 |
R. Quirion [Canada] | Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release |
| 000F58 |
A. J. Flint [Canada] ; S. E. Black ; I. Campbell-Taylor ; G. F. Gailey ; C. Levinton | Abnormal speech articulation, psychomotor retardation, and subcortical dysfunction in major depression |
| 000F98 |
D. B. Calne [Canada] ; B. J. Snow ; C. Lee | Criteria for diagnosing Parkinson's disease |
| 001007 |
S. J. Kish [Canada] ; K. Shannak ; A. Rajput ; J. H. N. Deck ; O. Hornykiewicz | Aging produces a specific pattern of striatal dopamine loss : implications for the etiology of idopathic Parkinson's disease |
| 001012 |
H. B. Niznik ; E. F. Fogel ; F. F. Fassos ; P. Seeman | The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus |
| 001024 |
J. C. S. Furtado [Canada] ; M. F. Mazurek | MPTP-induced neurotoxicity and the quest for a preventative therapy for Parkinson's disease |
| 001028 |
J. Poirier [Canada] ; S. Kogan ; S. Gauthier | Environment, genetics and idiopathic Parkinson's disease |
| 001032 |
O. S. Kofman [Canada] | Deprenyl : protective vs. symptomatic effect |
| 001033 |
D. B. Calne ; M. J. Zigmond | Compensatory mechanisms in degenerative neurologic diseases : insights from Parkinsonism |
| 001045 |
A. Fine | Transplantation of adrenal tissue into the central nervous system |
| 001053 |
M. Freedman | Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease |
| 001055 |
E. R. Vriezen [Canada] ; M. Moscovitch | Memory for temporal order and conditional associative-learning in patients with Parkinson's disease |
| 001063 |
C. Rouillard ; P. J. Bedard ; T. Di Paolo | Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393 |
| 001085 |
L. Tremblay ; M. Filion ; P. J. Bedard | Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism |
| 001093 |
G. S. Robertson ; D. G. Herrera ; M. Dragunow ; H. A. Robertson | L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra |
| 001098 |
S. M. Schnider ; R. H. Kwong ; F. A. Lenz ; H. C. Kwan | Detection of feedback in the central nervous system using system identification techniques |
| 001146 |
A. E. Lang | Manipulating the dopaminergic system in Parkinson's disease |
| 001182 |
M. Takada ; T. Hattori | Collateral projections from the substantia nigra to the cingulate cortex and striatum in the rat |
